Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

New American Cancer Society process for creating trustworthy cancer screening guidelines.

Brawley O, Byers T, Chen A, Pignone M, Ransohoff D, Schenk M, Smith R, Sox H, Thorson AG, Wender R.

JAMA. 2011 Dec 14;306(22):2495-9. doi: 10.1001/jama.2011.1800.

PMID:
22166609
2.

Practice bulletin no. 122: Breast cancer screening.

American College of Obstetricians-Gynecologists.

Obstet Gynecol. 2011 Aug;118(2 Pt 1):372-82. doi: 10.1097/AOG.0b013e31822c98e5. No abstract available.

PMID:
21775869
3.

Media coverage of U.S. preventive services task force recommendations: a commentary.

Petitti DB, Calonge N.

Am J Prev Med. 2011 May;40(5):579-80. doi: 10.1016/j.amepre.2011.02.009. No abstract available.

PMID:
21496760
4.

The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.

Squiers LB, Holden DJ, Dolina SE, Kim AE, Bann CM, Renaud JM.

Am J Prev Med. 2011 May;40(5):497-504. doi: 10.1016/j.amepre.2010.12.027.

PMID:
21496748
5.

United States Preventive Services Task Force screening mammography recommendations: science ignored.

Hendrick RE, Helvie MA.

AJR Am J Roentgenol. 2011 Feb;196(2):W112-6. doi: 10.2214/AJR.10.5609.

PMID:
21257850
6.

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW.

CA Cancer J Clin. 2010 Mar-Apr;60(2):99-119. doi: 10.3322/caac.20063. Review.

7.

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.

Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW.

J Am Coll Radiol. 2010 Jan;7(1):18-27. doi: 10.1016/j.jacr.2009.09.022.

PMID:
20129267
8.

Benefits of screening mammography.

Berg WA.

JAMA. 2010 Jan 13;303(2):168-9. doi: 10.1001/jama.2009.1993. No abstract available.

9.

The benefits and harms of mammography screening: understanding the trade-offs.

Woloshin S, Schwartz LM.

JAMA. 2010 Jan 13;303(2):164-5. doi: 10.1001/jama.2009.2007. No abstract available.

PMID:
20068211
10.

The 2009 breast cancer screening recommendations of the US Preventive Services Task Force.

Woolf SH.

JAMA. 2010 Jan 13;303(2):162-3. doi: 10.1001/jama.2009.1989. No abstract available.

PMID:
20068210
11.

Mammography screening: after the storm, calls for more personalized approaches.

Peres J.

J Natl Cancer Inst. 2010 Jan 6;102(1):9-11. doi: 10.1093/jnci/djp496. Epub 2009 Dec 18. No abstract available.

PMID:
20023204
12.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010. Erratum in: Ann Intern Med. 2010 Jan 19;152(2):136.

13.

Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. Review.

14.

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

US Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236. doi: 10.7326/0003-4819-151-10-200911170-00008. Erratum in: Ann Intern Med. 2010 May 18;152(10):688. Ann Intern Med. 2010 Feb 2;152(3):199-200.

PMID:
19920272
15.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

16.

Is there a role for decision aids in cancer-related decisions?

Neuman HB, Charlson ME, Temple LK.

Crit Rev Oncol Hematol. 2007 Jun;62(3):240-50. Epub 2007 Feb 20. Review.

PMID:
17317206
17.

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process.

Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T; International Patient Decision Aids Standards (IPDAS) Collaboration.

BMJ. 2006 Aug 26;333(7565):417. Epub 2006 Aug 14.

18.

Effect of screening and adjuvant therapy on mortality from breast cancer.

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators.

N Engl J Med. 2005 Oct 27;353(17):1784-92.

19.

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Humphrey LL, Helfand M, Chan BK, Woolf SH.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60.

PMID:
12204020
20.

Explaining risks: turning numerical data into meaningful pictures.

Edwards A, Elwyn G, Mulley A.

BMJ. 2002 Apr 6;324(7341):827-30. Review. No abstract available.

Supplemental Content

Support Center